CD274 and small cell lung carcinoma: PD-1/PD-L1 inhibitors have achieved remarkable curative effect in various malignant tumors such as non-SCLC, liver cancer, bladder cancer, and head and neck squamous cell carcinoma, which brought a survival benefit to patients [5].